Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
British Journal of Clinical Pharmacology|April 6, 1999
Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazoleN Brynne, Y Böttiger, B Hallén, et al.
Psychopharmacology Series|January 1, 1989
E-10-hydroxynortriptyline: effects and disposition of a potential novel antidepressantL Bertilsson, M L Dahl-Puustinen, C Nordin
Clinical Pharmacology and Therapeutics|April 1, 1986
Amitriptyline metabolism: association with debrisoquin hydroxylation in nonsmokersB Mellström, J Säwe, L Bertilsson, et al.
Therapeutic Drug Monitoring|August 1, 1994
Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring serviceM Jerling, L Lindström, U Bondesson, et al.
Life Sciences|September 24, 1984
Weak binding of 10-hydroxymetabolites of nortriptyline to rat brain muscarinic acetylcholine receptorsA Wägner, B Ekqvist, L Bertilsson, et al.
Clinical Pharmacology and Therapeutics|February 1, 1982
Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entitiesM Eichelbaum, L Bertilsson, J Säwe, et al.
British Journal of Clinical Pharmacology|February 15, 2000
Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genesP Dalén, M Dahl, K Andersson, et al.
British Journal of Clinical Pharmacology|June 1, 1985
Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratioC Nordin, B Siwers, J Benitez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1989
Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney, and intestine. Organ-specific differences in enantioselectivityM L Dahl-Puustinen, E Dumont, L Bertilsson
Chemico-Biological Interactions|August 1, 1971
Studies on the metabolism and pharamcokinetics of nortriptyline and desmethylimipramine in manB Alexanderson, L Bertilsson, O Borgå, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
British Journal of Clinical Pharmacology|April 6, 1999
Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazoleN Brynne, Y Böttiger, B Hallén, et al.
Psychopharmacology Series|January 1, 1989
E-10-hydroxynortriptyline: effects and disposition of a potential novel antidepressantL Bertilsson, M L Dahl-Puustinen, C Nordin
Clinical Pharmacology and Therapeutics|April 1, 1986
Amitriptyline metabolism: association with debrisoquin hydroxylation in nonsmokersB Mellström, J Säwe, L Bertilsson, et al.
Therapeutic Drug Monitoring|August 1, 1994
Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring serviceM Jerling, L Lindström, U Bondesson, et al.
Life Sciences|September 24, 1984
Weak binding of 10-hydroxymetabolites of nortriptyline to rat brain muscarinic acetylcholine receptorsA Wägner, B Ekqvist, L Bertilsson, et al.
Clinical Pharmacology and Therapeutics|February 1, 1982
Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entitiesM Eichelbaum, L Bertilsson, J Säwe, et al.
British Journal of Clinical Pharmacology|February 15, 2000
Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genesP Dalén, M Dahl, K Andersson, et al.
British Journal of Clinical Pharmacology|June 1, 1985
Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratioC Nordin, B Siwers, J Benitez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1989
Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney, and intestine. Organ-specific differences in enantioselectivityM L Dahl-Puustinen, E Dumont, L Bertilsson
Chemico-Biological Interactions|August 1, 1971
Studies on the metabolism and pharamcokinetics of nortriptyline and desmethylimipramine in manB Alexanderson, L Bertilsson, O Borgå, et al.
Pageof 27